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Background: Intersphincteric resection (ISR) has been used to avoid permanent colostomy in very low rectal
cancer patients. This study aimed to assess the surgical safety and oncologic and functional outcomes of ISR.
Methods: The records of 30 consecutive very low rectal cancer patients who underwent ISR without neoadjuvant
therapy were retrospectively analyzed; survival and locoregional recurrence rates were calculated by the
Kaplan-Meier method. Incontinence was assessed by a functionality questionnaire and the Wexner score.
Results: The median distance between the distal margin of the dentate line was 10 mm. A total of 12, 4, and 14
patients underwent partial ISR, subtotal ISR, and total ISR, respectively. The mean distal resection margin was
negative in all cases, and circumferential resection margin was positive in two cases. Morbidity was 33.3%:
anastomotic stricture in seven patients, colonic J-pouch prolapse in two patients, and an anovaginal fistula in one
patient. During the median, 56.2-month follow-up period, local, distant, and combined recurrences occurred in four,
three, and two patients, respectively. The 5-year overall and disease-free survival rates were 76.5% and 68.4%,
respectively. Local recurrence rates were 5.2% for the patients with Tis-T2 tumors as compared with 45.5% for those
with T3 tumors (P = 0.008). The mean Wexner scores and stool frequencies, 12 months after stoma closure in 19
patients, were 11.5 and 6.6 per 24 h, respectively. Significant differences were not seen in the Wexner scores
between partial ISR and subtotal/total ISR (11.8 ± 2.6 and 9.1 ± 5.6). Stool frequency (P = 0.02), urgency (P = 0.04),
and fragmentation (P = 0.015) were worse in patients with anastomotic stricture than in those without; there was
no symptom improvement in patients with anastomotic stricture.
Conclusions: The anastomotic strictures in patients undergoing ISR may have negatively affected anal function. For
total ISR patients, at least, informed consent stating the possibility of a permanent colostomy is necessary.
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Over the last two decades, surgical treatment for patients
with very low rectal cancer has radically evolved, allowing
permanent colostomy to be avoided in these patients.
Reappraisal of the distal margin has allowed increased po-
tency of sphincter-preserving resections. Moreover, total
mesorectal excision (TME) [1], coupled with techniques
such as end-anal stapling and coloanal anastomosis using
the double-stapling technique (DST) [2], can be used to* Correspondence: tokoro@surg.med.kindai.ac.jp
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reproduction in any medium, provided the orpreserve the sphincter without compromising on the
oncological results [3-5].
However, when the tumor is located close to the den-
tate line, conventional anterior resection using the inter-
peritoneal approach with DST may not allow a secure
distal resection margin. To resolve this problem, partial
or total internal sphincteric resection (ISR) and coloanal
anastomosis per anus can be used for safe surgical resec-
tion of the tumor [6-11]. ISR has been proposed to
achieve distal clearance in selected patients with very
low rectal tumors extending to the upper part of the
internal sphincter muscle. Furthermore, it has beenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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continence, and reduce the numbers of patients requir-
ing a permanent stoma.
ISR has been widely recognized to achieve a safe distal
resection margin, which can be as small as 1 to 2 cm
[12,13]. However, with this procedure, which involves
dividing the rectum between the internal sphincter and
the external sphincter or the levator ani, it remains un-
clear whether a secure circumferential resection margin
(CRM) of the tumor can be obtained. Further, partial or
total ISR procedures have been shown to possibly inter-
fere with fecal continence [7,8,14-16].
Anal incontinence is considered to influence various
factors in patients receiving ISR, including preoperative
radiation therapy [17,18], reconstruction methods [9], ex-
tent of sphincter preservation [19], tumor level, and height
of the anastomosis [20]. Moreover, fecal incontinence-
related quality of life (QOL) scores were poorer in ISR
patients than the patients with low anterior resection [16].
Although ISR was proposed as an alternative procedure to
avoid abdominoperineal resection (APR), a colostomy is a
viable option for patients who suffer from fecal incontin-
ence, which offers a definitive cure along with an improved
quality of life [21].
To evaluate the feasibility of ISR in very low rectal
cancer patients, it is necessary to clarify the oncologic
results and functional outcomes related to this proced-
ure. The aims of this study were to evaluate the surgical
safety of the procedure, to assess its oncologic and func-
tional outcomes, and to identify factors predictive of
anal dysfunction in the absence of radiotherapy.
Methods
Patients
We reviewed the medical charts of all 30 consecutive
patients who had undergone ISR for very low rectal
adenocarcinoma between April 2001 and August 2010 at
the Department of Surgery, Faculty of Medicine, Kinki
University. Written informed consent forms concerning
this procedure were obtained for all patients in our
hospital. In all cases, tumor stage was evaluated before
surgery by digital examination; colonoscopy; chest, ab-
dominal and pelvic computed tomography (CT); and
pelvic magnetic resonance imaging (MRI). Anorectal
manometry was not routinely performed. Preoperative
criteria for the exclusion of patients for ISR were
clinical T4 tumors, poorly differentiated adenocarcin-
oma (revealed by biopsy specimens), infiltrating gross ap-
pearance of the tumors, and some degree of preoperative
incontinence. Among patients with T1 tumors considered
for transanal local excision, ISR was proposed for those
patients with a risk of lymph node metastases in the case
of tumors with adverse pathologic features. Resectable
distant metastases were not a preoperative exclusioncriterion for ISR, and therefore, ISR was performed in one
patient with synchronous liver metastasis.
The histopathological findings and tumor stage clas-
sification were based on the Union for International
Cancer Control (UICC) TNM classification (seventh
edition) [22]. In Japan, preoperative chemoradiother-
apy (CRT) for resectable T3 rectal tumors, irrespective
of lymph node involvement, was not routinely performed,
and none of the patients included in this study had
received preoperative CRT or pre or postoperative
radiotherapy.
Surgical technique
The principle of the ISR procedure is based on an ana-
tomic dissection plane between the internal sphincter
muscle, which is an extension of the muscular layer of
the rectum, and the external sphincter muscle. Surgical
intervention was commenced with a high ligation of the
inferior mesenteric artery using the abdominal approach.
The rectum was dissected to the levator ani with TME.
Further, the intersphincteric plane was entered from the
nearest anorectal junction if possible. If this dissection
was technically difficult to perform until a sufficient dis-
tal margin was obtained via the abdominal approach,
then the transanal approach of the operation was com-
menced after perineal exposure using a retractor (Lone
Star retractor, Lone Star Medical Products Inc, Houston,
TX, USA). The distal margin was 1 cm for Tis-T2
tumors, and 2 cm below the inferior extent of the tumor
for T3 tumors. Total ISR involved complete excision of
the internal sphincter muscle, that is, the distal line of
resection was along the intersphincteric groove. For par-
tial ISR, the distal resection line was along the dentate
line, and for subtotal ISR, the distal resection line ran
from the dentate line to intersphincteric groove [11,19].
If the tumor was close to the external sphincter or the
levator ani muscle, additional partial external sphincter
resection (ESR) [11] was performed.
The proximal rectal side of the cut edge was immedi-
ately closed and irrigated with 1,500 ml of a 5%
povidone-iodine solution to reduce the risk of tumor-
cell dissemination [7,23]. Then, the dissection was
carried out longitudinally along the plane between the
internal and external sphincters to reach the abdominal
excision. After the rectum was removed through the
abdomen, colonic J-pouch and anal anastomosis proce-
dures with interrupted suture were performed. The
anastomosis was protected with a diverting loop ileos-
tomy or transverse colostomy in all the patients.
Follow-up and local recurrences
All 30 patients were followed for a median of 56.2
months (range; 13.3 to 168.4 months), and 20 patients
were available for follow-up for more than 2 years. All
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cluding a clinical examination with digital palpation, and
laboratory tests, including tumors markers (carcinoem-
bryonic antigen (CEA), CA-19-9), every 3 months for
the first 3 years, and then every 6 months for 2 years,
and then once a year. Abdominal and pelvic computed
tomography and chest radiography were performed
every 6 months for the first 3 years. A colonoscopy was
performed 3 or 6 months after surgery for planning
stoma closure, and then once every year for 3 years.
Most patients with stage III rectal cancer received post-
operative chemotherapy with oral tegafur, uracil, and/or
folic acid for 6 to 12 months. Local recurrence was
defined as the presence of any anastomotic, pelvic, or
lateral node recurrences documented either by clinical
or pathologic exanimation, irrespective of the presence
of distant metastases.Table 1 Clinicopathological characteristics of patients
who received intersphincteric resection (n = 30)
Characteristic Value











Tumor size, cma 3.8 ± 1.5
<4 cm 18Anal functional assessments
Functional outcomes were assessed using our functional
questionnaire. We prospectively collected questionnaires
regarding anal function from our patients every 3
months after closure of the diverting stoma. In this
questionnaire, patients were asked about stool frequency
(number of bowel movements per 24 h), fecal urgency
(ability to defer stool evacuation for >15 minutes), stool
fragmentation (>2 evacuations in 1 h), dyschesia (taking
more than 15 minutes to defecate), nocturnal defecation,
use of intestinal transit regulators, and need to wear a
pad. Incontinence was assessed by the Wexner contin-
ence score [24], and we considered anal function to be
poor if the Wexner score was 15 or more at 12 months
[17,18]. Anastomotic stricture or occlusion was deter-
mined when the surgeon’s forefinger could not pass













aValues denote mean ± SD.
bDifferentiation of adenocarcinoma: G1 = well differentiated; G2 = moderately
differentiated; Muc = mucinous carcinoma. Circ = circumferential tumor.Statistical analysis
Statistical analyses were performed using JMP10 soft-
ware (SAS Institute Inc., Cary, NC, USA). Overall and
disease-free survival were analyzed using Kaplan-Meier
curves and the log rank test. For disease-free survival,
patients who failed locally, systemically, or both were
censored at the time of the first failure.
Univariate and multivariate regression analyses were
used to evaluate the impact of age, gender, type of sur-
gery, type of reconstruction, and anastomotic stricture.
The changes in anal function between the different
groups of patients over time were compared using
Wilcoxon signed-rank test, and comparisons between
the anastomotic stricture group and the non-stricture
groups were performed using the Mann–Whitney U test.
Statistical significance was indicated at the P <0.05 level.Results
Patients and tumor characteristics are shown in Table 1.
During the study period, ISR covered 144 patients
(26.3%) who underwent surgery for lower-third rectal
cancer, located below the peritoneal reflex, 49 patients of
conventional anterior resection with DST, 35 patients of
abdominoperineal resection, and 20 patients of local
excision. The study population was made up of 30
patients (16 men and 14 women) with a median age of
58.9 years (range, 31 to 75 years); 1 patient (3.3%) had a
pTis of a large villous tumor, 8 patients had a pT1 tumor
(26.7%), 10 patients had a pT2 tumor (33.3%) and 11
patients had a pT3 tumor (36.7%). According to the
UICC TNM classification system, the tumors were clas-
sified as stage 0 in 1 patient, stage I in 16 patients, stage
IIA in 5 patients, stage IIIB in 5 patients, and stage IVA
in 1 patient.
Tokoro et al. World Journal of Surgical Oncology 2013, 11:24 Page 4 of 8
http://www.wjso.com/content/11/1/24Surgical and histopathological findings are shown in
Table 2.
In this study, partial ISR, subtotal ISR, and total ISR
were performed in 12, 4, and 14 patients, respectively.
Furthermore, 4 of 11 patients (36.4%) with T3 tumors
intraoperatively decided to undergo additional partial ESR.
The mean distance between the distal edge of the tumor
and the dentate line was 8.9 ± 8.0 mm (range, -3 to 25
mm) in all the patients. Tumor location was significantly
different for each ISR procedure (partial ISR, 16.0 ± 4.6
mm; subtotal ISR, 5.0 ± 4.1 mm; total ISR, 3.5 ± 5.1 mm).
Assessment of the fixed surgical specimens revealed
that the median distal edge of the tumor was 7 mm
(range, 3 to 22 mm), and it was negative in all cases.
The median circumferential margin of the tumor was 3
mm (range, 0.5 to 9 mm). The circumferential resection
margin was positive (<1 mm) in two patients with T3
tumor without partial ESR. Reconstruction of the co-
lonic J-pouch was performed in 26 patients, and straight
coloanal anastomosis was performed in 4 patients due to
narrow pelvis or bulky mesocolic fat tissue.
Mortality and morbidity
There was no mortality. Complications were encoun-
tered in ten patients (33.3%). Anastomotic leakage oc-
curred in seven patients, who were treated with perianal
drainage. The colonic J-pouch prolapsed in two patients
who underwent total ISR. One patient had an anovaginal
fistula, requiring repair of fistula using perineal muscular
rotation flap, and subsequent stoma closure. Anasto-
motic stricture or complete occlusion of an anastomosis
occurred in seven patients. Of these seven patients, fiveTable 2 Differences in clinicopathological characteristics








Male 6 2 6
Female 6 2 8
Type of reconstruction
Colonic J-pouch 9 4 13
Straight 3 0 1
Combined with partial ESR 0 2 2
Distance between the distal
edge of the tumor andthe
dentate line, mma
16.0 ± 4.6 5.0 ± 4.1 3.5 ± 5.1
Distal resection margin, mma 8.7 ± 6.0 9.5 ± 10.5 7.2 ± 5.4
CRM, mma 3.2 ± 2.7 4.8 ± 3.1 3.6 ± 2.1
No. of stoma closuresb 9 (81.8) 2 (50) 8 (57.1)
aValues indicate mean ± SD.
bData in parentheses represent percentage values in each group.
CRM = circumferential resection margin; ESR = external sphincteric resection;
ISR = intersphincteric resection.patients required dilation of the anastomosis using finger
bougie, endoscopic balloon dilation, or surgical stricture
plasty before stoma closure. Two patients suffered com-
plete occlusion of the anastomosis.
Oncologic results
Local, distant, and combined recurrence occurred in
four, three, and two patients, respectively. Six patients
died of cancer recurrence. For all patients who received
ISR, the 5-year overall and disease-free survival rates
were 76.5% and 68.4%, respectively.
The median disease-free interval for six patients with
local recurrence was 13 months (range, 8 to 14 months)
(Table 3). All of the four isolated local recurrence epi-
sodes developed within the first 2 years. All the patients
who experienced local recurrence had pT3 tumors, ex-
cept one patient who had a pT2 tumor. The local recur-
rence rates were significantly lower in patients with Tis
to T2 tumors (5.2%) than in those with T3 tumors
(45.5%; P = 0.008; Figure 1).
Aspects of stoma closure
Of the 29 ISR patients, excluding 1 with stage IVA dis-
ease, 19 (65.5%) underwent stoma closure by February
2010, including 3 patients who had undergone straight
anastomosis. The median interval between ISR and
stoma closure was 7 months (range, 3 to 14 months).
The median follow-up interval after stoma closure was
35 months (range, 4 to 68 months). Nine, two, and eight
patients received stoma closure in the partial ISR, sub-
total ISR, and total ISR groups, respectively (Table 2).
Definitive stoma closure could not be performed in 11
patients. Of the 11 patients, 5 had insufficient anal con-
dition (complete anastomotic occlusions in 2, prolapse
of colonic J-pouch in 2, obvious loose anastomosis in 1).
The patients who developed colonic J-pouch prolapse or
obvious loose anastomosis had received total ISR. Four
patients were diagnosed with distant metastases or local
relapse of the disease before stoma closure. Two patients
did not undergo stoma closure for social reasons. Three
out of four patients with additional partial ESR did not
achieve stoma closure because of a colonic J-pouch pro-
lapse or local recurrence.
Evaluation of anal function
Anal function was evaluated in 19 patients who under-
went stoma closure. At 12 months after stoma closure,
the mean Wexner score for all patients was 11.5 (range,
1 to 19). In the patients with partial ISR, the Wexner
scores were improved from 13.0 ± 3.1 at 3 months to
12.1 ± 3.0 at 6 months (P = 0.04). In contrast, in the
patients with subtotal or total ISR, no significant differ-
ences were found between the Wexner scores at 3
months and 6 months (13.0 ± 3.8 and 11.5 ± 4.9,
Table 3 Characteristics of six patients with local recurrence after intersphincteric resection (ISR)













1 IIA T3 G2 tISR + pESR 7 2 Pelvic wall NS CRT 45 months, O
2 IIIB T3 G2 sISR + pESR 25 2 Pelvic wall NS CRT 70 months, S
3 IIIB T3 G2 pISR 12 5 Pelvic wall Bone, lung Cx 31 months, P
4 IIA T3 G2 pISR 10 0.5 Lateral node Adrenal gland Cx 36 months, P
5 I T2 G1 pISR 3 6 Anastomosis NS APR 22 months, S
6 IIB T3 G1 pISR 3 0.5 Lateral node NS CRT 17 months, S
Distal resection margins and circumferential resection margins were measured on the histological slides.
APR = abdominoperineal resection; CRT = chemoradiotherapy; Cx = chemotherapy; ESR = external intersphincteric resection; ISR = intersphincteric resection;
NS = not stated; O = other origin of death; P = primary death; S = survived.
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observed in the Wexner scores at 6 months and 12
months (11.5 ± 4.9 vs 9.1 ± 5.6, respectively, P = 0.06).
At 3, 6, and 12 months, the Wexner scores were not sig-
nificantly different between patients who underwent par-
tial and subtotal or total ISR (Table 4). In the patients
without anastomotic stricture, the Wexner scores were
significantly improved at 6 months and 12 months com-
pared with those at 3 months. However, five patients, in-
cluding the one with subtotal ISR and an additional
partial ESR, required finger bougie, endoscopic balloon
dilation, or stricture plasty for anastomotic stricture, no
improvement in the Wexner score was observed.
Table 5 shows the anal function based on the ques-
tionnaires answered at 3, 6, and 12 months after stoma
closure, with or without anastomotic stricture. At 12
months after stoma closure, patients without anasto-
motic stricture were showed improved urgency (from
12/14 to 3/12; P = 0.008) and nocturnal defecation (from
9/14 to 5/12; P = 0.014). However, patients with anasto-
motic stricture did not report improvement in any symp-
tom. Compared to patients with anastomotic stricture, the
non-stricture group showed significantly better results withFigure 1 Rates of local recurrence among 30 patients
undergoing intersphincteric resection according to the
pathologic depth of the tumors (T stage).regard to stool frequency (5.1 ± 2.9 vs 9.0 ± 5.3; P = 0.02),
urgency (3/12 vs 4/5; P = 0.04), and fragmentation (4/12 vs
5/5; P = 0.015) at 12 months.
The results of the univariate analysis revealed that poor
anal function, as assessed by the Wexner score, was sig-
nificantly associated with gender (male; P = 0.047) and the
presence of anastomotic stricture (P = 0.018) at 12
months. The surgical procedure (partial or subtotal/total
ISR), type of reconstruction (straight or colonic J-pouch),
and age (<70 or ≥70) were not significantly associated with
anal function. The results of the multivariate analysis also
showed that gender (P = 0.283) was not significantly asso-
ciated with anal function and that the presence of anasto-
motic stricture (P = 0.093) only demonstrated a trend
towards being significantly associated with anal function
(data not shown).
Discussion
Although ISR is the sphincter-preserving procedure for
very low rectal cancer, there are concerns regarding local
control and defecatory function. In this study, we report
the outcomes of ISR of very low rectal cancer, less than
2.5 cm from the dentate line, with a median follow-up
period of 56 months. Our data show that this operation
is feasible, with no postoperative mortality found in the
study group. Moreover, it is associated with favorableTable 4 Wexner scores at 3, 6, and 12 months in patients
who underwent intersphincteric resection (ISR) followed
by stoma closure
Procedure/findings 3 months 6 months 12 months
Surgical procedure
Partial ISR (n = 9) 13.3 ± 3.1 12.1 ± 3.0* 11.8 ± 2.6
Subtotal or total ISR (n = 10) 13.0 ± 3.8 11.5 ± 4.9 9.1 ± 5.6
Anastomotic stricture
Yes (n = 5) 15.4 ± 2.9 13.4 ± 4.5 13.6 ± 3.9
No (n =14) 12.4 ± 3.3 11.2 ± 3.9* 9.0 ± 4.5*
Data are shown as mean ± SD. Data at 6 and 12 months were statistically
compared with those at 3 months using the Wilcoxon signed-rank test.
*P <0.05.




3 months 6 months 12 months
Non-stricture Stricture Non-stricture Stricture Non-stricture Stricture
Stool frequency, times/day 6.4 ± 3.6 11.4 ± 3.0** 6.8 ± 2.8 7.0 ± 2.1 5.1 ± 2.9 9.0 ± 5.3**
Urgency 12/14 4/5 8/13 2/5 3/12* 4/5**
Fragmentation 10/14 5/5 7/13 4/5 4/12 5/5**
Dyschesia 2/14 3/5 2/13 0/5 2/12 0/5
Medication use 4/14 4/5 3/13 4/5** 2/12 3/5
Nocturnal defecation 9/14 5/5 5/13* 5/5 5/12* 4/5
Data associated with each anal dysfunction at 6 and 12 months were statistically compared with those at 3 months for each condition of anastomotic sites using
Wilcoxon signed-rank test. *P <0.05.
Data associated with each anal dysfunction of the stricture group were statistically compared with those of the non-stricture group at 3, 6, and 12 months using
the Mann–Whitney U test. **P <0.05.
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the Wexner score, total ISR did not produce worse
outcomes than partial ISR did, with the exception that
permanent stoma were necessitated by unfavorable anas-
tomosis. However, anastomotic stricture, which occurred
as a postoperative complication, was found to negatively
affect anal function.
From an oncological point of view, local control of the
disease remains the most important objective in rectal
cancer surgery. The local recurrence rate of very low
rectal cancer for ISR varied widely, ranging between 0%
[23] to 31% [25]. With ISR, the rate of secure distal re-
section margin was in the range of 95% [23] to 100%
[18], and our results showed a median distance of 7 mm,
and a definite negative distal margin in all patients.
Therefore, ISR was found to provide an optimal distal
resection margin, which is difficult to attain by using
only the abdominal approach for very low rectal cancer.
Rate of positive CRM of the rectal cancer also influenced
factor of local recurrence. In our study group, 6.7% of all
patients had a CRM ≤1 mm, and similar results were
reported in the range of 0% to 13.3% [18,26]. Preoperative
CRT was considered useful for preventing local recur-
rence in low rectal cancer patients requiring ISR [14,23].
Kuo et al. [26] reported a positive CRM rate of 13.3%, but
a local recurrence rate of 7.7% in their ISR series of 26
patients; 88.5% of these patients had undergone preopera-
tive CRT. Paradoxically, Hohenberger and colleagues [27]
reported that in ISR patients with lower-third rectal
cancer without radiotherapy, the local recurrence rate was
high, at 46.5%. In our study, local recurrence was signifi-
cantly higher in patients with T3 tumors than in those
with Tis-T2 tumors. Akasu et al. [28] reported that both
T3 tumors and a positive microscopic resection margin in
patients who underwent ISR were significantly associated
with local recurrence. Because ISR involves dissection of
the rectum between the internal sphincter muscle and the
external sphincter muscle, in patients with T3 tumors with
expanding microscopic tumor cells near the levator ani orthe external sphincter muscles, during surgical resection,
there is a considerable risk of cutting into the tumor or
achieving a very short distance of a few millimeters to the
CRM. Thus, for a group of patients with T3 tumors, ISR
was applied to attain good responses to neoadjuvant CRT,
leading to secure CRM.
Partial or total resection of the internal sphincter
muscle resulted in defecatory dysfunction with frequent
defecation, urgency, and fecal incontinence [16,18,29].
Moreover, preoperative radiotherapy against T3 tumors
or lymph node involvement was found to have a nega-
tive impact on anal function after ISR [17,18,26]. In the
study by Ito et al. [17], of all the patients who underwent
ISR, 40% received radiotherapy and were found to have
a mean Wexner score of 10 at 12 months. Moreover,
Denost et al. [20] reported a median Wexner score of 11
in most of the patients who received radiotherapy.
It has been shown that colonic J-pouch reconstruction in
conjunction with ISR can minimize the anal dysfunction-
related side effects of a sphincteric resection [9]. Hida et al.
[30] reported the long-term benefits of colonic J-pouch re-
construction suggesting that it improves reservoir func-
tion to a greater extent than straight anastomosis does,
especially in patients in whom the anastomosis is less than
4 cm from the anal verge. In addition, Dennett et al. [31]
reported that colonic J-pouch is effective in very low rectal
cancer surgery, causing apparent reduction in the inci-
dence of anastomotic leaks and in bowel frequency. In our
study, the mean Wexner score was 11.5 in most patients
with colonic J-pouch reconstruction, and none of the
patients had received radiation therapy. In previous
studies, total ISR was performed in 8.9% [29] to 33.7%
[20] of all the ISR patients. A possible reason for the
poorer outcomes about Wexner score in our study was
that the number of patients who required total ISR
accounted for approximately half the ISR patients (42.1%),
because coloanal anastomosis using conventional DST
was technically possible in a few patients who required
partial ISR during our study period.
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after total ISR than after subtotal or partial ISR [19,20].
In our results for Wexner scores, anal function between
total or subtotal ISR and partial ISR were not different,
but patients of partial ISR had earlier recovery than
those of subtotal or total ISR. Our functional results are
limited because of the differences in stoma closure rates
between partial ISR and subtotal/total ISR patients. The
rates of stoma closure in patients with subtotal or total
ISR were lower than those in patients undergoing partial
ISR. This result in itself indicates poor anal function out-
comes for subtotal/total ISR. Especially with respect to
the three patients with total ISR, stoma closure was not
possible because of the high risk of major incontinence.
Postoperative complication rates varied between
reported series from 18% to 64% [15]. Common compli-
cations included leakage, anastomotic stricture, fistula,
pelvic sepsis, and prolapse. In a previous literature re-
view, anastomotic leakage rates of 5% to 48% [32] were
reportedly associated with ISR, and they varied depend-
ing on whether asymptomatic leaks were radiologically
detected. Also, Tilney and Tekkis [9] reviewed 21 studies
and reported an overall anastomotic leak rate of 10.5%
and anastomotic stricture rate of 5.8%. Similar rates
were reported in the current series: anastomotic leakage
occurred in 7 of 30 patients (23.3%) and anastomotic
stricture in 12% of the patients. Anastomotic leakage is
an important feature since it has been found to lead to
postoperative anastomotic stricture [33] and poor post-
operative anorectal function [34]. However, in our study,
there were no independent factors associated with anal
dysfunction in the multivariate analysis, but patients
with anastomotic stricture showed worse outcomes
(frequency, urgency, and fragmentation) than patients
without anastomotic stricture. In addition, symptoms
related to anal function were not reduced in these
patients. In our study, anastomotic stricture or occlusion
occurred in five of seven patients with anastomotic leak-
age; thus, stricture formation could be attributed to leak-
age caused by ischemia or infection of the anastomotic
site. Therefore, it is necessary to fully explain the possi-
bility of fecal incontinence or of a permanent stoma to
the patients before obtaining informed consent. Fecal
QOL in our patients who had an anastomotic stricture
was worse, and they might have little benefit from
preserving the anal continuity with ISR.
Our study has some limitations: it was a retrospect-
ive study and the sample size was relatively small.
There could be potential bias due to possible differ-
ence between those who were ambitious of receiving
the anal sphincter preserving surgery and those who
did not, which could affect the self-evaluation for
gastrointestinal questionnaire. With regard to the add-
itional partial ESR performed only in one patient withstoma closure, this was not taken into consideration while
estimating anal function.
Conclusions
In summary, ISR is an oncologically safe procedure for
pTis or pT2 tumors among very low rectal cancer
patients. Also, total ISR, that is, complete removal of the
internal sphincter muscles, carried risks of worse anal
function or possibility of a permanent stoma. The com-
plications associated with anastomosis, especially sten-
osis, resulted in poorer anal function. Larger studies are
needed to evaluate functional results in ISR patients
who suffer from anastomotic stricture.
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